Al-Ola A Abdallah, Director of Plasma Cell Disorder Program at the University of Kansas Medical Center, shared a post on X:
“Highlight from ICE-T2025
CancerNetwork spoke with Dr. Nausheen Ahmed at the inaugural National Immune Cell Effector Therapy (ICE-T) Conference.
Focus: Making CAR T-cell therapy safer and more accessible for patients nationwide. See Full article.”
More posts featuring Al-Ola A Abdallah on OncoDaily.